BioLineRx Drug Shows Anti-Tumor Activity In Brain Tumor Animal Models - BioLine Rx (NASDAQ:BLRX)

BioLineRx shares new GLIX1 glioblastoma data showing anti-tumor activity, including in temozolomide-resistant cancer models.

Raccontata dabenzinga.com